The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*

Research output: Contribution to journalJournal articleResearchpeer-review

Virological failure of first-generation nonnucleoside reverse transcriptase inhibitors (NNRTIs) can compromise the efficacy of etravirine as a result of the accumulation of NNRTI resistance mutations. How quickly NNRTI resistance accumulates in patients with a delayed switch from nevirapine or efavirenz despite virological failure, when these drugs are used as a component of combination antiretroviral therapy (cART), remains unclear.
Original languageEnglish
JournalHIV Medicine
Volume13
Issue number1
Pages (from-to)62-72
Number of pages11
ISSN1464-2662
DOIs
Publication statusPublished - Jan 2012

ID: 48505077